These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Recruitment of the tyrosine phosphatase Src homology 2 domain tyrosine phosphatase-2 to the p85 subunit of phosphatidylinositol-3 (PI-3) kinase is required for insulin-like growth factor-I-dependent PI-3 kinase activation in smooth muscle cells. Kwon M; Ling Y; Maile LA; Badley-Clark J; Clemmons DR Endocrinology; 2006 Mar; 147(3):1458-65. PubMed ID: 16306077 [TBL] [Abstract][Full Text] [Related]
23. Targeting therapeutic liabilities engendered by PIK3R1 mutations for cancer treatment. Cheung LW; Mills GB Pharmacogenomics; 2016 Feb; 17(3):297-307. PubMed ID: 26807692 [TBL] [Abstract][Full Text] [Related]
24. Expression of a mutated form of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase in a Hodgkin's lymphoma-derived cell line (CO). Jücker M; Südel K; Horn S; Sickel M; Wegner W; Fiedler W; Feldman RA Leukemia; 2002 May; 16(5):894-901. PubMed ID: 11986952 [TBL] [Abstract][Full Text] [Related]
25. Class IA PI3K regulatory subunits: p110-independent roles and structures. Fox M; Mott HR; Owen D Biochem Soc Trans; 2020 Aug; 48(4):1397-1417. PubMed ID: 32677674 [TBL] [Abstract][Full Text] [Related]
26. The negative regulation of phosphoinositide 3-kinase signaling by p85 and it's implication in cancer. Luo J; Cantley LC Cell Cycle; 2005 Oct; 4(10):1309-12. PubMed ID: 16131837 [TBL] [Abstract][Full Text] [Related]
27. Direct association of p110 beta phosphatidylinositol 3-kinase with p85 is mediated by an N-terminal fragment of p110 beta. Hu P; Schlessinger J Mol Cell Biol; 1994 Apr; 14(4):2577-83. PubMed ID: 8139559 [TBL] [Abstract][Full Text] [Related]
28. In vivo functional analysis of the counterbalance of hyperactive phosphatidylinositol 3-kinase p110 catalytic oncoproteins by the tumor suppressor PTEN. Andrés-Pons A; Rodríguez-Escudero I; Gil A; Blanco A; Vega A; Molina M; Pulido R; Cid VJ Cancer Res; 2007 Oct; 67(20):9731-9. PubMed ID: 17942903 [TBL] [Abstract][Full Text] [Related]
29. Phosphatidylinositol-3 kinase p85 enhances expression from the myelin basic protein promoter in oligodendrocytes. Clark RE; Miskimins WK; Miskimins R J Neurochem; 2002 Nov; 83(3):565-73. PubMed ID: 12390518 [TBL] [Abstract][Full Text] [Related]
30. A PI3K activity-independent function of p85 regulatory subunit in control of mammalian cytokinesis. García Z; Silio V; Marqués M; Cortés I; Kumar A; Hernandez C; Checa AI; Serrano A; Carrera AC EMBO J; 2006 Oct; 25(20):4740-51. PubMed ID: 17024187 [TBL] [Abstract][Full Text] [Related]
31. The p85beta regulatory subunit of PI3K serves as a substrate for PTEN protein phosphatase activity during insulin mediated signaling. He J; de la Monte S; Wands JR Biochem Biophys Res Commun; 2010 Jul; 397(3):513-9. PubMed ID: 20515662 [TBL] [Abstract][Full Text] [Related]
32. The p85 regulatory subunit controls sequential activation of phosphoinositide 3-kinase by Tyr kinases and Ras. Jimenez C; Hernandez C; Pimentel B; Carrera AC J Biol Chem; 2002 Nov; 277(44):41556-62. PubMed ID: 12196526 [TBL] [Abstract][Full Text] [Related]
33. Multiple roles for the p85α isoform in the regulation and function of PI3K signalling and receptor trafficking. Mellor P; Furber LA; Nyarko JN; Anderson DH Biochem J; 2012 Jan; 441(1):23-37. PubMed ID: 22168437 [TBL] [Abstract][Full Text] [Related]
34. Synergistic activation of a family of phosphoinositide 3-kinase via G-protein coupled and tyrosine kinase-related receptors. Katada T; Kurosu H; Okada T; Suzuki T; Tsujimoto N; Takasuga S; Kontani K; Hazeki O; Ui M Chem Phys Lipids; 1999 Apr; 98(1-2):79-86. PubMed ID: 10358930 [TBL] [Abstract][Full Text] [Related]
35. Phosphatidylinositol 3-kinase p85 adaptor function in T-cells. Co-stimulation and regulation of cytokine transcription independent of associated p110. Kang H; Schneider H; Rudd CE J Biol Chem; 2002 Jan; 277(2):912-21. PubMed ID: 11679587 [TBL] [Abstract][Full Text] [Related]
36. The structure of the inter-SH2 domain of class IA phosphoinositide 3-kinase determined by site-directed spin labeling EPR and homology modeling. Fu Z; Aronoff-Spencer E; Backer JM; Gerfen GJ Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3275-80. PubMed ID: 12629217 [TBL] [Abstract][Full Text] [Related]
37. The CC chemokine monocyte chemotactic peptide-1 activates both the class I p85/p110 phosphatidylinositol 3-kinase and the class II PI3K-C2alpha. Turner SJ; Domin J; Waterfield MD; Ward SG; Westwick J J Biol Chem; 1998 Oct; 273(40):25987-95. PubMed ID: 9748276 [TBL] [Abstract][Full Text] [Related]
38. The p85 and p110 subunits of phosphatidylinositol 3-kinase-alpha are substrates, in vitro, for a constitutively associated protein tyrosine kinase in platelets. Geltz NR; Augustine JA Blood; 1998 Feb; 91(3):930-9. PubMed ID: 9446654 [TBL] [Abstract][Full Text] [Related]
39. Acute ethanol exposure inhibits insulin signaling in the liver. He J; de la Monte S; Wands JR Hepatology; 2007 Dec; 46(6):1791-800. PubMed ID: 18027876 [TBL] [Abstract][Full Text] [Related]
40. Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival. Ueki K; Fruman DA; Brachmann SM; Tseng YH; Cantley LC; Kahn CR Mol Cell Biol; 2002 Feb; 22(3):965-77. PubMed ID: 11784871 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]